CVE-2023-32694

Non-constant time HMAC comparison in Adyen plugin in Saleor

Description

Saleor Core is a composable, headless commerce API. Saleor's `validate_hmac_signature` function is vulnerable to timing attacks. Malicious users could abuse this vulnerability on Saleor deployments having the Adyen plugin enabled in order to determine the secret key and forge fake events, this could affect the database integrity such as marking an order as paid when it is not. This issue has been patched in versions 3.7.68, 3.8.40, 3.9.49, 3.10.36, 3.11.35, 3.12.25, and 3.13.16.

Category

4.8
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.23%
Vendor Advisory github.com
Affected: saleor saleor
Published at:
Updated at:

References

Link Tags
https://github.com/saleor/saleor/security/advisories/GHSA-3rqj-9v87-2x3f vendor advisory
https://github.com/saleor/saleor/commit/1328274e1a3d04ab87d7daee90229ff47b3bc35e patch

Frequently Asked Questions

What is the severity of CVE-2023-32694?
CVE-2023-32694 has been scored as a medium severity vulnerability.
How to fix CVE-2023-32694?
To fix CVE-2023-32694, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-32694 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-32694 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-32694?
CVE-2023-32694 affects saleor saleor.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.